SlideShare ist ein Scribd-Unternehmen logo
1 von 4
Downloaden Sie, um offline zu lesen
WAY2WEALTH Securities Pvt. Ltd.,
3rd Floor, Tower B, Hincon House, 247 Park, LBS Road, Vikhroli (West) Mumbai - 400083. Tel +91 22 6146
email: research@way2wealth.com website: www.way2wealth.com
Way2wealth Research is also available on Bloomberg WTWL <GO>
WEEKLY TECHNICAL REPORT
I EQUITIES I
Nifty
BankNifty
27th
Jan 14
Prices in the past week provided the valid breakout
from the rising wedge providing upside price target
of 20800. Index gained 4.42% in the past week and is
likely to continue the upsurge until it hits our price
target of 20800. After such a sharp rise prices are
likely to retrace some of its rise before heading
northwards, immediate support is pegged at 19820 if
tested same can be used to create/add long
positions. Daily RSI is valued at 74.09 signaling test
of support level.
Action Entry Target Stop
Buy Around 19820 20800 19380
Note: The above levels are for BankNifty Spot.
In line with our expectations the Nifty inched high and
ended at 8835.6 which is all time high. Immediate
resistance in it is pegged at 8950 levels and some profit
booking from the same cannot be ruled out. Only a
sustainable rise above 9050 levels can take the index to
9200 or higher levels. Daily RSI is valued at 73.49 which
is overbought reading and is supporting some profit
booking around the resistance line. Immediate support
is pegged at 8625 levels if tested before resistance line
same can be used to initiate fresh long positions.
Action Entry Target Stop/Reversal
Sell Around 8940 8650 9060
Buy On dips at 8650 8940 8590
Note: The above levels are for Nifty Spot.
WAY2WEALTH Securities Pvt. Ltd.,
3rd Floor, Tower B, Hincon House, 247 Park, LBS Road, Vikhroli (West) Mumbai - 400083. Tel +91 22 6146 2900
email: research@way2wealth.com website: www.way2wealth.com
Way2wealth Research is also available on Bloomberg WTWL <GO>
WEEKLY TECHNICAL REPORT
I EQUITIES I
APOLLOHOSP Future
CIPLA Future Counter after hitting the life time high of 674 in late
October entered into a consolidation phase and in
the Friday’s session prices broke out from the
consolidation range. This consolidation of over two
months has resulted in a triangular pattern and has
provided price target of 835. Daily RSI is in line with
the price structure. Correction/pullback if any can
be used to initiate long position.
Action Entry Target Stop
Buy Around 675 760 635
The stock future after turning its direction from the
rising support line at 1089 has now penetrated the
rising resistance line pegged at 1262. This has
completed the rising wedge pattern on the daily
chart and same has provided the upside price target
of 1500. Daily RSI is valued at 76.85 is signaling
retest of the resistance turned support line likely at
1266. Same can be used to initiate long positions.
Action Entry Target Stop
Buy Around 1270 1390 1224
WAY2WEALTH Securities Pvt. Ltd.,
3rd Floor, Tower B, Hincon House, 247 Park, LBS Road, Vikhroli (West) Mumbai - 400083. Tel +91 22 6146 2900
email: research@way2wealth.com website: www.way2wealth.com
Way2wealth Research is also available on Bloomberg WTWL <GO>
WEEKLY TECHNICAL REPORT
I EQUITIES I
M&M Future
=
Prices after retracing 61.8% of previous impulse
wave from 1115 to 1428 consolidated in the range of
1210 to 1350. In the past week prices have broke out
from the trading range and now are likely to enter in
to uptrend. This can take prices to higher levels of
1480. Positive diversion visible in daily RSI is
supporting our bullish view in the counter.
Action Entry Target Stop
Buy Around 1355 1480 1299
WAY2WEALTH Securities Pvt. Ltd.,
3rd Floor, Tower B, Hincon House, 247 Park, LBS Road, Vikhroli (West) Mumbai - 400083. Tel +91 22 6146 2900
email: research@way2wealth.com website: www.way2wealth.com
Way2wealth Research is also available on Bloomberg WTWL <GO>
WEEKLY TECHNICAL REPORT
I EQUITIES I
DISCLAIMER
The contents of this material are general and are neither comprehensive nor appropriate for every individual and are solely for the
informational purposes of the readers. This material does not take into account the specific investment objectives, financial
situation or needs of an individual/s or a Corporate/s or any entity/s. A qualified professional should be consulted before making an
investment decisions or acting on any information contained in this material. All investments involve risk and past performance
does not guarantee future results. Investigate before you invest. You are strongly cautioned to verify any information before using
it for any personal or business purpose.
Way2wealth Brokers (P) Limited (herein after called Way2Wealth) does not guarantee the accuracy, quality or completeness of any
information. Much of the information is relevant only in India. Way2wealth makes no warranties, either express or implied,
including, but not limited to warranties of suitability, fitness for a particular purpose, accuracy, timeliness, completeness or non-
infringement.
In no event shall Way2Wealth be liable for any damages of any kind, including, but not limited to, indirect, special, incidental,
consequential, punitive, lost profits, or lost opportunity, whether or not Way2Wealth has advised of the possibility of such
damages.
This material contains statements that are forward-looking; such statements are based upon the current beliefs and expectations
and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking
statements. These uncertainties include but are not limited to: the risk of adverse movements or volatility in the securities markets
or in interest or foreign exchange rates or indices; adverse impact from an economic slowdown; downturn in domestic or foreign
securities and trading conditions or markets; increased competition; unfavorable political and diplomatic developments; change in
the governmental or regulatory policies; failure of a corporate event and such others. This is not an offer to buy or sell or a
solicitation of an offer to buy or sell any security or instrument or to participate in any particular trading strategy. No part of this
material may be copied or duplicated in any form by any means or redistributed without the written consent of Way2Wealth. In no
event shall any reader publish, retransmit, redistribute or otherwise reproduce any information provided by Way2Wealth in any
format to anyone. Way2Wealth and its affiliates, officers, directors and employees including persons involved in the preparation or
issuance of this report may from time to time have interest in securities thereof, of companies mentioned herein.

Weitere ähnliche Inhalte

Was ist angesagt?

Equity Accurate news By The Theequicom.com 2-April-14
 Equity Accurate news By The Theequicom.com 2-April-14 Equity Accurate news By The Theequicom.com 2-April-14
Equity Accurate news By The Theequicom.com 2-April-14
snehastocktips
 

Was ist angesagt? (20)

03 nov-17-daily-report
03 nov-17-daily-report03 nov-17-daily-report
03 nov-17-daily-report
 
Chennai Petroleum: Expect strong upside in the coming months - Way2wealth
Chennai Petroleum: Expect strong upside in the coming months - Way2wealthChennai Petroleum: Expect strong upside in the coming months - Way2wealth
Chennai Petroleum: Expect strong upside in the coming months - Way2wealth
 
Morning tea 29 09-2016
Morning tea 29 09-2016Morning tea 29 09-2016
Morning tea 29 09-2016
 
Way2wealth's Daily Forex Notes
Way2wealth's Daily Forex NotesWay2wealth's Daily Forex Notes
Way2wealth's Daily Forex Notes
 
Daily Equity Report Sai Proficient
Daily Equity Report Sai ProficientDaily Equity Report Sai Proficient
Daily Equity Report Sai Proficient
 
Daily Equity Newsletter by CapitalHeight for 11-04-2016
Daily Equity Newsletter by CapitalHeight for 11-04-2016Daily Equity Newsletter by CapitalHeight for 11-04-2016
Daily Equity Newsletter by CapitalHeight for 11-04-2016
 
Pick of the week britannia
Pick of the week britanniaPick of the week britannia
Pick of the week britannia
 
DAILY-OPTION-NEWS BY THEEQUICOM FOR 20-AUG-2013
DAILY-OPTION-NEWS BY THEEQUICOM FOR 20-AUG-2013DAILY-OPTION-NEWS BY THEEQUICOM FOR 20-AUG-2013
DAILY-OPTION-NEWS BY THEEQUICOM FOR 20-AUG-2013
 
Morning tea 31 01-2017
Morning tea 31 01-2017Morning tea 31 01-2017
Morning tea 31 01-2017
 
Market Wrap Up for 22nd October
Market Wrap Up for 22nd OctoberMarket Wrap Up for 22nd October
Market Wrap Up for 22nd October
 
Morning tea 06 03-2017
Morning tea 06 03-2017Morning tea 06 03-2017
Morning tea 06 03-2017
 
Morning tea 20 10-2016
Morning tea 20 10-2016Morning tea 20 10-2016
Morning tea 20 10-2016
 
Try these profitable equity trading tips
Try these profitable equity trading tipsTry these profitable equity trading tips
Try these profitable equity trading tips
 
Market Wrap Up: 30th November, 2010
Market Wrap Up: 30th November, 2010Market Wrap Up: 30th November, 2010
Market Wrap Up: 30th November, 2010
 
Morning tea 16 01-2017 (1)
Morning tea 16 01-2017 (1)Morning tea 16 01-2017 (1)
Morning tea 16 01-2017 (1)
 
EPIC RESEARCH SINGAPORE - Weekly SGX Singapore report of 21 March - 25 March ...
EPIC RESEARCH SINGAPORE - Weekly SGX Singapore report of 21 March - 25 March ...EPIC RESEARCH SINGAPORE - Weekly SGX Singapore report of 21 March - 25 March ...
EPIC RESEARCH SINGAPORE - Weekly SGX Singapore report of 21 March - 25 March ...
 
Morning tea 07 03-2017
Morning tea 07 03-2017Morning tea 07 03-2017
Morning tea 07 03-2017
 
Equity Accurate news By The Theequicom.com 2-April-14
 Equity Accurate news By The Theequicom.com 2-April-14 Equity Accurate news By The Theequicom.com 2-April-14
Equity Accurate news By The Theequicom.com 2-April-14
 
Equity report 16 july 2014
Equity report 16 july 2014Equity report 16 july 2014
Equity report 16 july 2014
 
Morning tea 16 11-2016
Morning tea 16 11-2016Morning tea 16 11-2016
Morning tea 16 11-2016
 

Andere mochten auch

Ed.D. in Educational Leadership K-12 at Dallas Baptist University
Ed.D. in Educational Leadership K-12 at Dallas Baptist UniversityEd.D. in Educational Leadership K-12 at Dallas Baptist University
Ed.D. in Educational Leadership K-12 at Dallas Baptist University
jenniferspeer
 
Online marketing in Russia
Online marketing in RussiaOnline marketing in Russia
Online marketing in Russia
LumoLink
 
21 – francisco trigueros – la actitud del profesor ante los nuevos retos (1 12)
21 – francisco trigueros – la actitud del profesor ante los nuevos retos (1 12)21 – francisco trigueros – la actitud del profesor ante los nuevos retos (1 12)
21 – francisco trigueros – la actitud del profesor ante los nuevos retos (1 12)
ANA HENRIQUEZ ORREGO
 
Estructura Y Wireframes
Estructura Y WireframesEstructura Y Wireframes
Estructura Y Wireframes
Adrian Estrada
 
Diabetes Prevention Program - DPPOS
Diabetes Prevention Program - DPPOSDiabetes Prevention Program - DPPOS
Diabetes Prevention Program - DPPOS
Oscar Suárez
 
Fotografía nocturna
Fotografía nocturnaFotografía nocturna
Fotografía nocturna
Bren Mut
 

Andere mochten auch (20)

Revista de verano - junio de 2014
Revista de verano - junio de 2014Revista de verano - junio de 2014
Revista de verano - junio de 2014
 
Hepatitis crónica
Hepatitis crónicaHepatitis crónica
Hepatitis crónica
 
Workshop CENIT Social Media
Workshop CENIT Social MediaWorkshop CENIT Social Media
Workshop CENIT Social Media
 
Angelina Jolie (Hermoso)
Angelina Jolie (Hermoso)Angelina Jolie (Hermoso)
Angelina Jolie (Hermoso)
 
La raiz cuadrada
La raiz cuadradaLa raiz cuadrada
La raiz cuadrada
 
Ed.D. in Educational Leadership K-12 at Dallas Baptist University
Ed.D. in Educational Leadership K-12 at Dallas Baptist UniversityEd.D. in Educational Leadership K-12 at Dallas Baptist University
Ed.D. in Educational Leadership K-12 at Dallas Baptist University
 
Online marketing in Russia
Online marketing in RussiaOnline marketing in Russia
Online marketing in Russia
 
21 – francisco trigueros – la actitud del profesor ante los nuevos retos (1 12)
21 – francisco trigueros – la actitud del profesor ante los nuevos retos (1 12)21 – francisco trigueros – la actitud del profesor ante los nuevos retos (1 12)
21 – francisco trigueros – la actitud del profesor ante los nuevos retos (1 12)
 
Estructura Y Wireframes
Estructura Y WireframesEstructura Y Wireframes
Estructura Y Wireframes
 
Web 2 - 4 - Metaweb
Web 2 - 4 - MetawebWeb 2 - 4 - Metaweb
Web 2 - 4 - Metaweb
 
Diabetes Prevention Program - DPPOS
Diabetes Prevention Program - DPPOSDiabetes Prevention Program - DPPOS
Diabetes Prevention Program - DPPOS
 
Tarea 2
Tarea 2 Tarea 2
Tarea 2
 
FISIOLOGIA SANGRE
FISIOLOGIA SANGREFISIOLOGIA SANGRE
FISIOLOGIA SANGRE
 
Prostodoncia Superficie pulida
Prostodoncia Superficie pulidaProstodoncia Superficie pulida
Prostodoncia Superficie pulida
 
Londinium
LondiniumLondinium
Londinium
 
Fotografía nocturna
Fotografía nocturnaFotografía nocturna
Fotografía nocturna
 
Biologia evolutiva (2)
Biologia evolutiva (2)Biologia evolutiva (2)
Biologia evolutiva (2)
 
The CGIAR Research Program on Dryland Systems: Scientific content and progre...
The CGIAR Research Program on Dryland Systems: Scientific content  and progre...The CGIAR Research Program on Dryland Systems: Scientific content  and progre...
The CGIAR Research Program on Dryland Systems: Scientific content and progre...
 
Pont du gard
Pont du gardPont du gard
Pont du gard
 
3. [en]bocm fs mrt mri
3. [en]bocm fs mrt mri3. [en]bocm fs mrt mri
3. [en]bocm fs mrt mri
 

Ähnlich wie Weekly Tech Picks: Buy Bank Nifty; likely to continue the upsurge

SBI: Buy for a target of Rs3480 - Way2wealth
SBI: Buy for a target of Rs3480 - Way2wealth SBI: Buy for a target of Rs3480 - Way2wealth
SBI: Buy for a target of Rs3480 - Way2wealth
IndiaNotes.com
 
Keynote technicals daily report for 030212
Keynote technicals   daily report for 030212Keynote technicals   daily report for 030212
Keynote technicals daily report for 030212
Keynote Capitals Ltd.
 

Ähnlich wie Weekly Tech Picks: Buy Bank Nifty; likely to continue the upsurge (20)

SBI: Buy for a target of Rs3480 - Way2wealth
SBI: Buy for a target of Rs3480 - Way2wealth SBI: Buy for a target of Rs3480 - Way2wealth
SBI: Buy for a target of Rs3480 - Way2wealth
 
Way2wealth's Daily Derivatives
 Way2wealth's Daily Derivatives Way2wealth's Daily Derivatives
Way2wealth's Daily Derivatives
 
Morning Tea 09-09-2015
Morning Tea 09-09-2015Morning Tea 09-09-2015
Morning Tea 09-09-2015
 
Today Stock Market Report by www.capitalheight.com
Today Stock Market Report by www.capitalheight.comToday Stock Market Report by www.capitalheight.com
Today Stock Market Report by www.capitalheight.com
 
Keynote technicals daily report for 030212
Keynote technicals   daily report for 030212Keynote technicals   daily report for 030212
Keynote technicals daily report for 030212
 
Morning Tea
Morning TeaMorning Tea
Morning Tea
 
Morning Tea 14-09-15
Morning Tea 14-09-15Morning Tea 14-09-15
Morning Tea 14-09-15
 
Morning tea 22 02-2017
Morning tea 22 02-2017Morning tea 22 02-2017
Morning tea 22 02-2017
 
Equity bazaar
Equity bazaarEquity bazaar
Equity bazaar
 
‬ Morning Tea
‬ Morning Tea‬ Morning Tea
‬ Morning Tea
 
Choice - Morning Tea
Choice - Morning TeaChoice - Morning Tea
Choice - Morning Tea
 
Morning tea 04 11-2016
Morning tea 04 11-2016Morning tea 04 11-2016
Morning tea 04 11-2016
 
Morning tea 28 06-2016
Morning tea 28 06-2016Morning tea 28 06-2016
Morning tea 28 06-2016
 
Morning tea 13 10-2016
Morning tea 13 10-2016Morning tea 13 10-2016
Morning tea 13 10-2016
 
Pick of the Week: LIC Housing Finance Ltd.
Pick of the Week: LIC Housing Finance Ltd.Pick of the Week: LIC Housing Finance Ltd.
Pick of the Week: LIC Housing Finance Ltd.
 
Morning Tea 11-09-15
Morning Tea 11-09-15Morning Tea 11-09-15
Morning Tea 11-09-15
 
Choice - Morning Tea
Choice - Morning TeaChoice - Morning Tea
Choice - Morning Tea
 
Techno buy usdinr 15122016
Techno buy usdinr 15122016Techno buy usdinr 15122016
Techno buy usdinr 15122016
 
Morning tea 15 02-2017
Morning tea 15 02-2017Morning tea 15 02-2017
Morning tea 15 02-2017
 
Equity bazaar
Equity bazaarEquity bazaar
Equity bazaar
 

Mehr von IndiaNotes.com

Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15
IndiaNotes.com
 

Mehr von IndiaNotes.com (20)

Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
 
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesHester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
 
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoVidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
 
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityApollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
 
Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16
 
Cummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtCummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debt
 
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
 
Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...
 
Capital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARECapital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARE
 
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
 
Canara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16ECanara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16E
 
Nirmal lupin 06_aug15
Nirmal lupin 06_aug15Nirmal lupin 06_aug15
Nirmal lupin 06_aug15
 
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
 
Hexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyHexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, Buy
 
Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15
 
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
 
Fce thermax 31_jul15
Fce thermax 31_jul15Fce thermax 31_jul15
Fce thermax 31_jul15
 
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyPI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
 

Weekly Tech Picks: Buy Bank Nifty; likely to continue the upsurge

  • 1. WAY2WEALTH Securities Pvt. Ltd., 3rd Floor, Tower B, Hincon House, 247 Park, LBS Road, Vikhroli (West) Mumbai - 400083. Tel +91 22 6146 email: research@way2wealth.com website: www.way2wealth.com Way2wealth Research is also available on Bloomberg WTWL <GO> WEEKLY TECHNICAL REPORT I EQUITIES I Nifty BankNifty 27th Jan 14 Prices in the past week provided the valid breakout from the rising wedge providing upside price target of 20800. Index gained 4.42% in the past week and is likely to continue the upsurge until it hits our price target of 20800. After such a sharp rise prices are likely to retrace some of its rise before heading northwards, immediate support is pegged at 19820 if tested same can be used to create/add long positions. Daily RSI is valued at 74.09 signaling test of support level. Action Entry Target Stop Buy Around 19820 20800 19380 Note: The above levels are for BankNifty Spot. In line with our expectations the Nifty inched high and ended at 8835.6 which is all time high. Immediate resistance in it is pegged at 8950 levels and some profit booking from the same cannot be ruled out. Only a sustainable rise above 9050 levels can take the index to 9200 or higher levels. Daily RSI is valued at 73.49 which is overbought reading and is supporting some profit booking around the resistance line. Immediate support is pegged at 8625 levels if tested before resistance line same can be used to initiate fresh long positions. Action Entry Target Stop/Reversal Sell Around 8940 8650 9060 Buy On dips at 8650 8940 8590 Note: The above levels are for Nifty Spot.
  • 2. WAY2WEALTH Securities Pvt. Ltd., 3rd Floor, Tower B, Hincon House, 247 Park, LBS Road, Vikhroli (West) Mumbai - 400083. Tel +91 22 6146 2900 email: research@way2wealth.com website: www.way2wealth.com Way2wealth Research is also available on Bloomberg WTWL <GO> WEEKLY TECHNICAL REPORT I EQUITIES I APOLLOHOSP Future CIPLA Future Counter after hitting the life time high of 674 in late October entered into a consolidation phase and in the Friday’s session prices broke out from the consolidation range. This consolidation of over two months has resulted in a triangular pattern and has provided price target of 835. Daily RSI is in line with the price structure. Correction/pullback if any can be used to initiate long position. Action Entry Target Stop Buy Around 675 760 635 The stock future after turning its direction from the rising support line at 1089 has now penetrated the rising resistance line pegged at 1262. This has completed the rising wedge pattern on the daily chart and same has provided the upside price target of 1500. Daily RSI is valued at 76.85 is signaling retest of the resistance turned support line likely at 1266. Same can be used to initiate long positions. Action Entry Target Stop Buy Around 1270 1390 1224
  • 3. WAY2WEALTH Securities Pvt. Ltd., 3rd Floor, Tower B, Hincon House, 247 Park, LBS Road, Vikhroli (West) Mumbai - 400083. Tel +91 22 6146 2900 email: research@way2wealth.com website: www.way2wealth.com Way2wealth Research is also available on Bloomberg WTWL <GO> WEEKLY TECHNICAL REPORT I EQUITIES I M&M Future = Prices after retracing 61.8% of previous impulse wave from 1115 to 1428 consolidated in the range of 1210 to 1350. In the past week prices have broke out from the trading range and now are likely to enter in to uptrend. This can take prices to higher levels of 1480. Positive diversion visible in daily RSI is supporting our bullish view in the counter. Action Entry Target Stop Buy Around 1355 1480 1299
  • 4. WAY2WEALTH Securities Pvt. Ltd., 3rd Floor, Tower B, Hincon House, 247 Park, LBS Road, Vikhroli (West) Mumbai - 400083. Tel +91 22 6146 2900 email: research@way2wealth.com website: www.way2wealth.com Way2wealth Research is also available on Bloomberg WTWL <GO> WEEKLY TECHNICAL REPORT I EQUITIES I DISCLAIMER The contents of this material are general and are neither comprehensive nor appropriate for every individual and are solely for the informational purposes of the readers. This material does not take into account the specific investment objectives, financial situation or needs of an individual/s or a Corporate/s or any entity/s. A qualified professional should be consulted before making an investment decisions or acting on any information contained in this material. All investments involve risk and past performance does not guarantee future results. Investigate before you invest. You are strongly cautioned to verify any information before using it for any personal or business purpose. Way2wealth Brokers (P) Limited (herein after called Way2Wealth) does not guarantee the accuracy, quality or completeness of any information. Much of the information is relevant only in India. Way2wealth makes no warranties, either express or implied, including, but not limited to warranties of suitability, fitness for a particular purpose, accuracy, timeliness, completeness or non- infringement. In no event shall Way2Wealth be liable for any damages of any kind, including, but not limited to, indirect, special, incidental, consequential, punitive, lost profits, or lost opportunity, whether or not Way2Wealth has advised of the possibility of such damages. This material contains statements that are forward-looking; such statements are based upon the current beliefs and expectations and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. These uncertainties include but are not limited to: the risk of adverse movements or volatility in the securities markets or in interest or foreign exchange rates or indices; adverse impact from an economic slowdown; downturn in domestic or foreign securities and trading conditions or markets; increased competition; unfavorable political and diplomatic developments; change in the governmental or regulatory policies; failure of a corporate event and such others. This is not an offer to buy or sell or a solicitation of an offer to buy or sell any security or instrument or to participate in any particular trading strategy. No part of this material may be copied or duplicated in any form by any means or redistributed without the written consent of Way2Wealth. In no event shall any reader publish, retransmit, redistribute or otherwise reproduce any information provided by Way2Wealth in any format to anyone. Way2Wealth and its affiliates, officers, directors and employees including persons involved in the preparation or issuance of this report may from time to time have interest in securities thereof, of companies mentioned herein.